Shares & the stockmarket
Russ Mould: what to expect when AstraZeneca and GSK report next week
Shares in both pharmaceutical companies slipped back in the final quarter of 2024.
Related videos:
27 February 2026
Russ Mould: The trio of insurers to watch out for in the coming week
20 February 2026
Russ Mould: Big Earnings Day. What to expect from NVIDIA, Diageo and HSBCAs the world's largest company by market capitalisation, NVIDIA's performance and guidance are...
13 February 2026
Russ Mould: Analysts dig into Antofagasta, Glencore, Rio Tinto, Anglo American numbers ahead of their updatesAJ Bell Investment Director, Russ Mould lists the companies scheduled to report in the week, and...
6 February 2026
Russ Mould: Analysts look at forthcoming results of FTSE 100 stalwartsAJ Bell Investment Director, Russ Mould runs through the names of companies scheduled to report...
30 January 2026
Russ Mould: Analysts zero in on GSK, Alphabet and Shell ahead of forthcoming resultsAJ Bell Investment Director, Russ Mould lists the companies scheduled to report in the week...
23 January 2026
Russ Mould: Headline numbers to look out for from the 'Magnificent Seven'AJ Bell Investment Director, Russ Mould runs through the names of companies scheduled to report...
16 January 2026
Russ Mould: Analysts look at Netflix, JD Sports and B&M ahead of forthcoming updatesAJ Bell Investment Director, Russ Mould runs through the names of companies scheduled to report...
9 January 2026
Russ Mould: Builders, Recruiters & Retail: Which companies to look at in the week aheadThis week, Russ Mould dives into a packed UK reporting calendar, from housebuilders like Persimmon...
